Katelyn Kozinski-Burkhart, PA
Physician Assistant · Bradenton, FLNPI 1962106955
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 116 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 27 manufacturers, the largest accounting for just 13.7% — the pattern of someone who eats at a lot of different presentations.
Across 116 payments — averaging $20.01 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$319
- Lilly USA, LLC$212
- Amgen$186
- Pfizer$180
- Otsuka America Pharmaceutical, Inc.$174
- Exact Sciences$166
- plus $1K from 21 others
What the payments were for
- Food & beverage$2,321100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 19 | $319 |
| Lilly USA, LLC | 10 | $212 |
| Amgen | 10 | $186 |
| Pfizer | 9 | $180 |
| Otsuka America Pharmaceutical, Inc. | 9 | $174 |
| Exact Sciences | 6 | $166 |
| GSK | 8 | $163 |
| Lundbeck LLC | 7 | $161 |
| Teva Pharmaceuticals USA, Inc. | 5 | $120 |
| Salix Pharmaceuticals, A Division Of Bausch Health US, LLC | 6 | $112 |
| Novo Nordisk | 3 | $67 |
| Boston Scientific | 2 | $43 |
| AbbVie | 2 | $41 |
| Boehringer Ingelheim | 2 | $40 |
| Paratek Pharmaceuticals, Inc. | 2 | $36 |
| Phathom Pharmaceuticals, Inc. | 2 | $35 |
| Shield Therapeutics Inc | 2 | $32 |
| Sumitomo Pharma America, Inc. | 1 | $30 |
| Nestle Healthcare Nutrition Inc. | 2 | $28 |
| Indivior Inc. | 1 | $27 |
| Sanofi-aventis U.S. LLC | 1 | $26 |
| Corium, LLC | 2 | $24 |
| Phadia US Inc. | 1 | $23 |
| Regeneron Healthcare Solutions, Inc. | 1 | $21 |
| Inari Medical, Inc. | 1 | $21 |
| Bayer | 1 | $19 |
| Dexcom, Inc. | 1 | $16 |
How this compares
$2,321 in reported general payments places this provider in the 75th percentile of 8,062 physician assistant providers in Florida.
Medicare billing
What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| Clonazepam | 98 | $1,192 |
| Tramadol Hcl | 54 | $897 |
| Pregabalin | 35 | $882 |
| Alprazolam | 121 | $724 |
| Zolpidem Tartrate | 79 | $615 |
| Eszopiclone | 11 | $509 |
| Dextroamphetamine-AmphetamineDextroamphetamine/Amphetamine | 11 | $488 |
| Temazepam | 33 | $313 |
| Hydrocodone-AcetaminophenHydrocodone/Acetaminophen | 21 | $197 |
| Diazepam | 21 | $171 |
| Doxycycline Hyclate | 19 | $166 |
| Lorazepam | 27 | $117 |
| Phenobarbital | 16 | $113 |
Paid to pharmacies, not to this prescriber.
Other physician assistant in Bradenton
- Audrey BeckerSt Augustine$689K
- Kevin WilliamsTampa$647K
- Brian BonomoLecanto$559K
- Melissa SingletonOcala$482K
- Reeli ReinuMaitland$427K
- Jeanelle KingMiami$424K
- Risha BellomoOrlando$397K
- Jason BergerClearwater$344K
- Ashley MillerGainesville$328K
- Nicole HillOrlando$319K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Billing: Medicare Physician & Other Practitioners, data year 2024. Original Medicare Part B only.
- Identity: NPPES NPI Registry, July 2026.